RVMD
Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
$140.55
-2.96% today
Updated 2026-04-29
Market cap
$29.88B
P/E ratio
—
P/S ratio
9,035.10x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$34 – $156
Volume
3.1M
Revolution Medicines Inc (RVMD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $15.08M | $170.59M | $220.53M | $567.40M | $737.99M | $811.93M | $2.06B | $2.56B |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Current assets | $9.44M | $85.43M | $133.98M | $454.12M | $589.77M | $660.18M | $1.88B | $2.33B |
| Total liabilities | $10.55M | $73.93M | $67.99M | $92.72M | $135.42M | $126.74M | $235.51M | $293.10M |
| Current liabilities | $7.60M | $30.55M | $43.05M | $47.18M | $60.35M | $61.98M | $143.85M | $163.91M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — |
| Retained earnings | $-67.93M | $-109.72M | $-157.39M | $-265.55M | $-452.64M | $-701.34M | $-1.14B | $-1.74B |
| Accounts receivable | — | $7.30M | $8.74M | $6.39M | $5.93M | $4.67M | $1.25M | $0.00 |
| Inventory | — | $6.60M | $1.00 | — | $-12.72M | $1.00 | $1.00 | — |
| Goodwill | $0.00 | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M |